By rebranding a weedkiller as essential to the Pentagon, Trump hands Bayer a legal shield worth billions while farmers and consumers absorb the health unknowns.
Late Wednesday night the White House published a three-page directive that flips a 76-year-old wartime statute into a corporate liability shield. The order cites the 1950 Defense Production Act to declare glyphosate—the active ingredient in Bayer-Monsanto’s Roundup—a “strategic and critical material” necessary for both military radar components and the nation’s food supply.
The practical impact is immediate: any federal or state rule that “places at risk the corporate viability” of the lone domestic producer can be overridden by the Agriculture and Defense secretaries. In plain English, Washington has immunized Bayer from future Roundup cancer suits that have already cost the company more than $10 billion in settlements and triggered a Supreme Court appeal set for this spring.
How a Post-Korean-War Law Became a Pesticide Escape Hatch
Congress passed the Defense Production Act so President Truman could reroute aluminum and rubber to tanks instead of toasters. The statute has since been tapped for 9/11 radio upgrades, COVID ventilators, and—during Trump’s first term—keeping meatpacking lines open as 293 workers died of the virus. Never before has it been stretched to protect a single agro-chemical already branded a “probable human carcinogen” by the World Health Organization in 2015.
The order’s language is sweeping: glyphosate and its chemical precursor elemental phosphorus are labeled “essential to national defense” because radar, solar cells, and sensors require the element. Critics note the Pentagon buys roughly 0.3 % of U.S. phosphorus output; farmers consume the rest. By bundling the two uses, the White House cloaks a farm chemical in the same legal armor given to F-35 titanium.
One Plant, One Billion Pounds, Zero Competition
America’s entire glyphosate supply now hinges on a single Louisiana facility owned by ICL Group, an Israeli conglomerate. The plant produces 300 million pounds of the herbicide a year—enough to spray half the nation’s soybean acres—yet still falls 6 million kilograms short of domestic demand, forcing imports from China. Trump’s directive tasks Agriculture Secretary Brook Rollins and Defense Secretary Pete Hegseth to “expand production capacity” and block any regulation that might dent ICL’s bottom line.
Consolidation alarms legal scholars. “When national security is invoked to override product-liability law, we’ve abandoned market discipline for monopoly protection,” says Sharon Treat, a former Maine state senator who drafted pesticide-reform bills. The order effectively socializes Bayer’s legal risk while privatizing the profit stream.
A $7.25 Billion Settlement Buys Political Cover
Forty-eight hours before the Oval Office signature, Bayer announced it would pay up to $7.25 billion to resolve the remaining Roundup cancer claims—on the condition the Supreme Court caps future lawsuits. The administration then filed a brief supporting Bayer’s federal pre-emption argument, insisting EPA labels should trump state cancer warnings. The executive order seals the deal by asserting that any state court verdict threatening “corporate viability” endangers national security.
Farmers Get Cheaper Chemicals, But at What Price?
U.S. growers apply glyphosate on 285 million acres annually—an area larger than Texas—because it costs as little as $7 per acre** and kills every weed except the patented Roundup-ready crop. The order promises “cost-effective production,” yet commodity prices remain stuck below the cost of production for a fourth straight year.
Jennifer Zwagerman, director of Drake University’s Agricultural Law Center, warns the directive “does nothing to address consolidation of seed, fertilizer, and chemical markets.” Four firms—Bayer, Corteva, Syngenta, and BASF—control 67 % of global pesticide sales, giving them pricing power even with federal subsidies.
MAHA Base Feels Betrayed
The move detonated the president’s populist health wing. Robert F. Kennedy Jr., who runs the “Make America Healthy Again” initiative, had issued reports linking glyphosate to childhood chronic illness. His spokesperson nonetheless endorsed the order, calling it a national-security imperative. The contradiction did not escape activists.
“Giving Bayer immunity is a middle finger to every MAHA mom,” said Ken Cook, president of the Environmental Working Group. Former Rep. Marjorie Taylor Greene amplified the revolt on X: “Trump just signed an EO protecting cancer-causing glyphosate in our foods.” The backlash spotlights a fracture between the administration’s agrichemical donors and its anti-toxin base ahead of 2026 midterms.
Global Backlash and Trade Fallout
The order arrives as the European Union finalizes a 2027 ban on glyphosate for non-agricultural use and Mexico phases out the chemical by 2030. U.S. exporters could face retaliatory tariffs on genetically engineered crops soaked in a herbicide Washington itself subsidizes. Meanwhile, China controls 84 % of elemental phosphorus refining; the directive’s import dependence undercuts the “America First” rhetoric.
Bottom Line—Risk Transferred, Not Eliminated
Washington has engineered a triple win for Bayer: a litigation cap via the Supreme Court, a federal pre-emption claim, and now a defense shield that brands Roundup as vital as uranium. The risk, however, has not vanished; it has merely morphed from courtroom verdicts to long-term public-health liabilities, export market access, and the political price of betraying the very voters who equate “MAHA” with poison-free food.
For faster, definitive coverage of the policies reshaping your plate and your paycheck, keep reading onlytrustedinfo.com—where every executive order is decoded before the ink dries.
